These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 30170097

  • 1. Methylglyoxal at metronomic doses sensitizes breast cancer cells to doxorubicin and cisplatin causing synergistic induction of programmed cell death and inhibition of stemness.
    Roy A, Sarker S, Upadhyay P, Pal A, Adhikary A, Jana K, Ray M.
    Biochem Pharmacol; 2018 Oct; 156():322-339. PubMed ID: 30170097
    [Abstract] [Full Text] [Related]

  • 2. Methylglyoxal in combination with 5-Fluorouracil elicits improved chemosensitivity in breast cancer through apoptosis and cell cycle inhibition.
    Ghosh S, Pal A, Ray M.
    Biomed Pharmacother; 2019 Jun; 114():108855. PubMed ID: 31003140
    [Abstract] [Full Text] [Related]

  • 3. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F, Duivenvoorden WC, Singh G.
    Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
    [Abstract] [Full Text] [Related]

  • 4. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
    Tyagi AK, Agarwal C, Chan DC, Agarwal R.
    Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: A mechanistic insight.
    Rai G, Mishra S, Suman S, Shukla Y.
    Phytomedicine; 2016 Mar 15; 23(3):233-42. PubMed ID: 26969377
    [Abstract] [Full Text] [Related]

  • 7. Sensitization of Hep3B hepatoma cells to cisplatin and doxorubicin by corilagin.
    Gambari R, Hau DK, Wong WY, Chui CH.
    Phytother Res; 2014 May 15; 28(5):781-3. PubMed ID: 23913631
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The Indole-3-carbinol cyclic tetrameric derivative CTet synergizes with cisplatin and doxorubicin in triple-negative breast cancer cell lines.
    De Santi M, Galluzzi L, Duranti A, Magnani M, Brandi G.
    Anticancer Res; 2013 May 15; 33(5):1867-72. PubMed ID: 23645732
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells.
    Chang YW, Singh KP.
    PLoS One; 2017 May 15; 12(3):e0174227. PubMed ID: 28323900
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reactive oxygen species-mediated synergistic and preferential induction of cell death and reduction of clonogenic resistance in breast cancer cells by combined cisplatin and FK228.
    Pluchino LA, Choudhary S, Wang HC.
    Cancer Lett; 2016 Oct 10; 381(1):124-32. PubMed ID: 27477899
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rational combination therapy of vintafolide (EC145) with commonly used chemotherapeutic drugs.
    Reddy JA, Dorton R, Bloomfield A, Nelson M, Vetzel M, Guan J, Leamon CP.
    Clin Cancer Res; 2014 Apr 15; 20(8):2104-14. PubMed ID: 24429878
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.